Dermatitis
Adult-onset eczema — what to try before jumping to biologics
Dupixent and the new JAK inhibitors are powerful tools — but they aren't the first move for most adults with eczema. Here's the ladder we use in clinic, what each step buys you, and when biologic therapy genuinely becomes the right call.
Published May 20, 2026 · 8 min read

Medically reviewed by Dr. Robert Tamayev, MD, PhD · Updated May 20, 2026
Key takeaways
- About 1 in 10 adults will have eczema at some point. Many cases that "appear in adulthood" are actually long-standing mild eczema that finally hit a threshold of triggers.
- The treatment ladder is well-defined: skin care + emollients → topical corticosteroids or topical calcineurin inhibitors → phototherapy → systemic medications (cyclosporine, methotrexate, or — increasingly — biologics and JAK inhibitors).
- Dupilumab (Dupixent) and JAK inhibitors (upadacitinib / Rinvoq, abrocitinib / Cibinqo) are genuinely transformative for moderate-to-severe disease, but they are step 4, not step 1. Most patients improve substantially before they get there.
- The single biggest under-used step in adult eczema is using topical steroids correctly — the right potency, the right amount (fingertip-unit dosing), for the right duration (2-week proactive bursts rather than indefinite daily application).
- A consistent, boring skin-care routine (gentle cleanser + emollient twice daily, no fragrance) outperforms almost every "newer" trick.
Eczema didn't really start when you were 35
Patients often arrive in our office saying their eczema "appeared out of nowhere" in their thirties or forties. In nearly every case, when we dig into the history, there was a long-standing mild atopic background — childhood dry skin, a brief period of hand dermatitis in college, sensitive scalp, hayfever growing up. The threshold for full-blown adult eczema is usually crossed when several triggers stack: a stressful year, a move to a new apartment with different water hardness, a new pet, a new job with more handwashing, perimenopause, or a new skincare product.
The good news: this means most of these patients are not in an unrecognizable disease category. They are on the atopic spectrum, and the treatment ladder works for them.
The ladder — what to actually try, in order
Step 1: Skin care basics (do this even if you do nothing else)
- Bathe in lukewarm water (not hot), 5-10 minutes maximum.
- Use a fragrance-free, soap-free gentle cleanser — CeraVe Hydrating Cleanser, La Roche-Posay Lipikar Syndet, or Cetaphil Gentle Cleansing Lotion are all reasonable.
- Pat dry and apply a thick emollient within 3 minutes of getting out of the bath or shower. Twice daily total. The classics: CeraVe Moisturizing Cream, Eucerin Original, Vanicream, or plain petrolatum (Vaseline). Ointments outperform creams which outperform lotions for active eczema.
- Skip every fragrance, every essential oil, every "natural" home remedy during a flare. Lavender oil is one of the most common positive patch-test reactions we see.
Most patients with mild-to-moderate eczema improve meaningfully with this step alone, executed consistently for 4-6 weeks.
Step 2: Topical corticosteroids — used correctly
This is the step most patients are doing wrong. Either they're afraid of topical steroids and not using enough, or they're using a high-potency steroid on the face long-term (where it can cause skin atrophy).
The fingertip-unit rule: one fingertip's worth of cream covers an area the size of two adult palms. A typical adult eczema flare on one arm needs about 3 fingertip units. Most patients are using a quarter of what's needed.
Potency by body area:
- Face, neck, groin, armpits: low-potency (hydrocortisone 1-2.5%) or non-steroidal alternatives (tacrolimus / Protopic ointment, pimecrolimus / Elidel cream)
- Trunk, limbs: mid-potency (triamcinolone 0.1%, mometasone 0.1%)
- Hands, feet, lichenified plaques: high-potency (clobetasol 0.05%, betamethasone 0.05%)
Duration: for an active flare, twice-daily application for 7-14 days, then taper. For chronic stubborn areas, twice-weekly proactive application (on already-cleared skin, two days a week) prevents most relapses without the side effects of daily use.
The biggest mistake I see in adult eczema patients isn't the choice of drug — it's the dose. Patients use a pea-size amount on a whole arm, see no benefit, and conclude steroids don't work for them. They work; they just have to actually reach the skin in enough quantity to do anything.
— Taina Lopez Cartagena, DNP, Asthma Allergy Care & Treatment
Step 3: Topical calcineurin inhibitors and crisaborole
For the face and other thin-skinned areas where you don't want long-term steroids, the alternatives are:
- Tacrolimus 0.1% ointment (Protopic) — non-steroidal, safe for long-term use, mild burning on first application that resolves within a week.
- Pimecrolimus 1% cream (Elidel) — milder, often used for facial eczema in children and adults.
- Crisaborole 2% ointment (Eucrisa) — a PDE-4 inhibitor, also non-steroidal, approved for mild-to-moderate atopic dermatitis.
Step 4: Phototherapy
Narrowband UVB phototherapy 2-3 times per week in a dermatology clinic is highly effective for moderate-to-severe eczema and avoids systemic medication. Downside: time commitment (12-24 weeks of in-office visits), cost, and reduced availability in some NYC neighborhoods. We refer patients here when topicals plateau.
Step 5: Systemic medications — biologics and JAK inhibitors
When the disease is moderate-to-severe and not adequately controlled by steps 1-4, we escalate to systemic therapy. Modern options:
- Dupilumab (Dupixent) — an IL-4/IL-13 biologic, subcutaneous injection every 2 weeks. FDA-approved for moderate-to-severe atopic dermatitis. About 70% of patients see ≥50% improvement; many see ≥75% improvement.
- Tralokinumab (Adbry) — IL-13 specific biologic. Comparable efficacy to dupilumab for many patients.
- Lebrikizumab (Ebglyss) — another IL-13 biologic, monthly maintenance dosing once established.
- Upadacitinib (Rinvoq) and abrocitinib (Cibinqo) — oral JAK inhibitors. Often faster onset than biologics. Black-box warnings around cardiovascular and infection risk; we screen carefully.
Older systemic options (cyclosporine, methotrexate, azathioprine) still have a role but generally now reserved for biologic failures or specific cases.
The realistic timeline
A reasonable expectation for adult eczema treatment:
- Weeks 1-2: Skin-care basics + correct topical steroid use. Most patients feel meaningful improvement.
- Weeks 3-6: If still not controlled, add proactive twice-weekly maintenance topical, consider tacrolimus on face/neck.
- Months 2-4: If still not controlled, evaluate for patch testing (rule out contact dermatitis component) and consider phototherapy.
- Month 4+: If still moderate-to-severe and impacting quality of life, escalate to biologic or JAK inhibitor.
About 60% of adult eczema patients we see never need to escalate past step 2 if it's done correctly.
When to see an allergist (or dermatologist)
Book a visit if any of these apply:
- The eczema is interfering with sleep, work, or relationships
- You've been on topical steroids for more than 4 weeks without clearing
- You're getting frequent skin infections (eczema herpeticum, impetigo)
- You suspect a contact-allergy component (rash matches the shape of a product, a metal, a glove)
- You have multiple atopic conditions (asthma + allergic rhinitis + eczema)
Go to urgent care or an emergency department if you develop a rapidly spreading rash with fever, pus, or facial swelling — eczema herpeticum and superinfections need same-day evaluation.
Frequently asked questions
Can adults really develop eczema for the first time?
Truly first-time-in-adulthood eczema is unusual but not rare. More often, what looks like new-onset adult eczema is mild lifelong atopic disease that hit a threshold. Either way, the diagnosis is clinical and the treatment ladder is the same.
Are topical steroids dangerous if I use them long-term?
Used correctly, no. The risks (skin thinning, stretch marks) come from high-potency steroids used continuously on thin-skinned areas for many weeks. The modern approach — proactive twice-weekly application after the flare is cleared — has been studied long-term and is safe.
How does dupilumab compare to oral steroids for eczema?
Dupilumab is dramatically safer for long-term use than oral prednisone. Oral steroids work fast but the side-effect burden over months or years is real (osteoporosis, weight gain, glucose intolerance, mood changes). For chronic moderate-to-severe eczema, dupilumab is now the preferred chronic systemic option for most patients.
Will the JAK inhibitor warnings affect me?
The black-box warnings on JAK inhibitors come from older rheumatology data and apply mainly to patients with cardiovascular risk factors, smoking history, or prior malignancy. For a young or middle-aged eczema patient without those risk factors, the absolute risk is low — but it's a conversation we have in detail before prescribing.
Should I get allergy testing for my eczema?
For classic atopic dermatitis, food allergy testing usually doesn't change management. But for hand eczema, facial eczema with a clear pattern, or eczema that worsens with specific exposures, patch testing for delayed contact allergens can be high yield. We assess case by case.
Last reviewed
Last reviewed May 20, 2026 by Dr. Robert Tamayev, MD, PhD. Last substantive update May 20, 2026.
References
- Wollenberg A et al. European guideline (EuroGuiDerm) on atopic eczema — Part 1: systemic therapy. J Eur Acad Dermatol Venereol. 2022;36(9):1409-1431.
- AAAAI / ACAAI Joint Task Force. Atopic Dermatitis: Practice Parameter Update. Ann Allergy Asthma Immunol. 2024.
- Simpson EL et al. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. N Engl J Med. 2016;375:2335-2348.
- Eichenfield LF et al. Guidelines of care for the management of atopic dermatitis. J Am Acad Dermatol. 2014;71(1):116-132.
- ACAAI Patient Resources. Eczema (Atopic Dermatitis). American College of Allergy, Asthma & Immunology — acaai.org (accessed 2026-05-20).

